ASLAN003 is a novel, potent and orally bioavailable inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) which has the potential to be first-in-class in AML (Acute Myelogenous Leukemia). ASLAN003 has antitumor activity.

纯度：≥98%

CAS：1035688-66-4